Advertisement
Screener

908 DEVICES INC. (MASS) Debt / Equity

908 Devices Inc. Debt/Equity Ratio

The debt/equity ratio shows how much a company has borrowed for every dollar its shareholders have put in. It is long-term debt, both the part due within a year and the rest, divided by shareholder equity, shown as a multiple with both amounts in the table. A higher ratio means the company relies more on borrowed money than on shareholder capital. Because equity shrinks through buybacks or losses, the ratio can rise even when debt is unchanged, and it has no meaning when equity is negative. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.

  • 908 Devices Inc. debt/equity ratio for the quarter ending 2021-03-31 was 0.11.
  • 908 Devices Inc. debt/equity ratio for the quarter ending 2020-12-31 was 0.11.
  • 908 Devices Inc. debt/equity ratio for fiscal 2020 was 0.11.
Available history
2020-12-31 to 2021-03-31
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity RatioLong-term debtShareholder equity
2021-03-310.11$15M$133.31M
2020-12-310.11$14.83M$139.04M

Annual Debt/Equity Ratio

DateDebt/Equity RatioLong-term debtShareholder equity
2020-12-310.11$14.83M$139.04M

Similar stocks

Stock NameCountryMarket CapPE Ratio
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B